Date | Time | Source | Headline | Symbol | Company |
03/29/2019 | 3:00AM | UK Regulatory | AIM Cancellation - Akers Biosciences, Inc. | LSE:AKR | Akers Bio |
03/06/2019 | 5:23AM | Alliance News | Shareholders Approve Akers Biosciences Shares Delisting At March-End (ALLISS) | LSE:AKR | Akers Bio |
03/06/2019 | 2:00AM | UK Regulatory | Akers Biosciences, Inc. Result of Special Meeting of Shareholders | LSE:AKR | Akers Bio |
02/06/2019 | 4:00AM | UK Regulatory | Akers Biosciences, Inc. Holding in Company | LSE:AKR | Akers Bio |
02/06/2019 | 2:01AM | UK Regulatory | Akers Biosciences, Inc. Form DEFA14A Filing - Additional Proxy Materials | LSE:AKR | Akers Bio |
02/06/2019 | 2:00AM | UK Regulatory | Akers Biosciences, Inc. Notice of Special Meeting of Shareholders | LSE:AKR | Akers Bio |
02/05/2019 | 8:00AM | UK Regulatory | Akers Biosciences, Inc. Further Re. Directorate Change | LSE:AKR | Akers Bio |
01/28/2019 | 2:00AM | UK Regulatory | Akers Biosciences, Inc. Form PRE 14A Filing | LSE:AKR | Akers Bio |
12/28/2018 | 10:45AM | UK Regulatory | Akers Biosciences, Inc. Director/PDMR Shareholding | LSE:AKR | Akers Bio |
12/19/2018 | 11:59AM | Alliance News | Akers Biosciences Plans To Exit AIM Market By Next March (ALLISS) | LSE:AKR | Akers Bio |
12/19/2018 | 11:45AM | UK Regulatory | Akers Biosciences, Inc. Intention to Delist from AIM | LSE:AKR | Akers Bio |
12/18/2018 | 1:00PM | UK Regulatory | Akers Biosciences, Inc. Issue of Equity | LSE:AKR | Akers Bio |
12/10/2018 | 2:00AM | UK Regulatory | Akers Biosciences, Inc. Result of AGM & Form 8-K Filing | LSE:AKR | Akers Bio |
11/26/2018 | 9:00AM | UK Regulatory | Akers Biosciences, Inc. Further Re. Notice of AGM | LSE:AKR | Akers Bio |
11/19/2018 | 9:25AM | Alliance News | Akers Biosciences Evaluates Opportunities In Cannabis Sector | LSE:AKR | Akers Bio |
11/19/2018 | 9:00AM | UK Regulatory | Akers Biosciences, Inc. Further Re. Strategic Update | LSE:AKR | Akers Bio |
11/19/2018 | 8:56AM | Alliance News | Akers Biosciences Restored To Trading On AIM Following Stock Split (ALLISS) | LSE:AKR | Akers Bio |
11/19/2018 | 2:30AM | UK Regulatory | AIM Restoration - Akers Biosciences, Inc | LSE:AKR | Akers Bio |
11/16/2018 | 11:00AM | UK Regulatory | Akers Biosciences, Inc. Reverse Stock Split Update | LSE:AKR | Akers Bio |
11/15/2018 | 9:00AM | Alliance News | Akers Biosciences Third-Quarter Loss Widens On Admin And Legal Costs | LSE:AKR | Akers Bio |
11/15/2018 | 2:01AM | UK Regulatory | Akers Biosciences, Inc. 3rd Quarter 2018 Results | LSE:AKR | Akers Bio |
11/15/2018 | 2:01AM | UK Regulatory | Akers Biosciences, Inc. Notice of AGM | LSE:AKR | Akers Bio |
11/12/2018 | 2:00AM | UK Regulatory | Akers Biosciences, Inc. Form 8-K Filing | LSE:AKR | Akers Bio |
11/08/2018 | 6:59AM | Alliance News | Akers Biosciences Shares Suspended Following Reverse Stock Split (ALLISS) | LSE:AKR | Akers Bio |
11/08/2018 | 2:30AM | UK Regulatory | AIM Suspension - Akers Biosciences, Inc. | LSE:AKR | Akers Bio |
11/08/2018 | 2:00AM | UK Regulatory | Akers Biosciences, Inc. Temporary Suspension of Share Trading on LSE | LSE:AKR | Akers Bio |
11/07/2018 | 10:28AM | Alliance News | Akers Biosciences Evaluates Options, To Undertake Reverse Stock Split (ALLISS) | LSE:AKR | Akers Bio |
11/07/2018 | 10:02AM | Alliance News | *Akers Biosciences Undertakes 1-For-8 Reverse Stock Split (ALLISS) | LSE:AKR | Akers Bio |
11/07/2018 | 10:01AM | Alliance News | *Akers Biosciences To Evaluate Strategic Alternatives To Maximize Shareholder Value | LSE:AKR | Akers Bio |
11/07/2018 | 9:50AM | UK Regulatory | Akers Biosciences, Inc. Strategic Update & Reverse Stock Split | LSE:AKR | Akers Bio |